奔二胺救援药物用于集群的管理:现实世界的追溯结果
Sharon Chiang1,2, Robert Moss3, Sunita N Misra4
1Department of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, California, USA.
Epilepsia
|November 28, 2024
概括
二胺救援药物可能提供超过急性集群终止的长期益处. 这些治疗方法的早期使用与长时间的无间隔有关,特别是在女性中.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 现实世界的证据研究研究.
背景情况:
- 二是急性发作集群终止的标准药物.
- 之前的分析表明,戴泽帕姆鼻雾剂的潜在长期影响.
- 需要真实世界的数据来探索这些影响.
研究的目的:
- 为了测试是否与未经治疗的群体相比,二治疗的发作群体的下一个群体的时间比未经治疗的群体更长.
- 分析早期二甲类药物给药对群发作频率的影响.
- 为了研究二胺救援药物的潜在长期影响.
主要方法:
- 对扣押追踪器TM数据库 (2007-2022) 的回顾性分析.
- 卡普兰-梅尔分析用于比较治疗和未治疗组之间的时间到下一次发作集群.
- 对每个群体的发作进行混合效应分析.
- 使用各种发作集群定义进行敏感性分析.
主要成果:
- 与未经治疗的集群 (0.8天) 相比,佐地亚zepine救援管理之后的中位时间到下一个发作集群 (4.9天) 的时间明显更长.
- 这种效应在一小部分患者中更为明显,主要是女性.
- 在一个集群内早期的治疗与每个集群的发作较少相关.
结论:
- 现实世界的数据表明,类药物可能具有超出急性终止的效果.
- 较早的使用二类药物似乎提高了它们的疗效.
- 这些发现支持了子类药物在发作集群管理中的可能长期益处的假设.
相关概念视频
Anxiolytic Drugs: Benzodiazepines and Buspirone
523
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
523
Sedatives and Hypnotics Drugs: Benzodiazepines
194
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
194
CNS Depressants: Barbiturates and Benzodiazepines
224
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
224
Sedatives and Hypnotics: Overview
279
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
279
Sedatives and Hypnotics Drugs: Barbiturates
196
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
196
Antiepileptic Drugs: Potassium Channel Activators
146
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
146


